Citations

Showing 10 of 108162 citations.

B-cell prolymphocytic leukemia has 3 subsets
Kay, Neil E. , Hanson, Curtis A. , Kay, Neil E

Mayo Clinic

Blood | November 21, 2019 | Volume: 134 | Issue: 21 | Pages: 1777-1778

10.1182/blood.2019003046 | PMID 31751477 Get It

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Dalgaard, Frederik , Mulder, Hillary, Wojdyla, Daniel , Alexander, John H. , Caterina, Raffaele De , Washam, Jeffrey B. , García, David , Wallentin, Lars , Granger, Christopher B. , Mulder, Hillary , Granger, Christopher B , Mulder, Hillary , Lópes, Renato D. , Held, Claes , Hylek, Elaine M. , Gersh, Bernard J. , Al‐Khatib, Sana M.

Mayo Clinic

Circulation | November 21, 2019 | Volume: 141 | Issue: 1 | Pages: 10-20

10.1161/circulationaha.119.041296 | PMID 31747786 Get It

Background: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) with oral anticoagulants has been associated with an increased risk of bleeding. We investigated the risk of bleeding and major cardiovascular outcomes in patients with atrial fibrillation taking NSAIDs and apixaban or warfarin. Methods: The ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; n=18 201) compared apixaban with warfarin in patients with atrial fibrillation at an increased risk of stroke. Patients in ARISTOTLE without severe renal (creatine clearance ≤30 mL/min) or liver disease were included in this analysis (n=17 423). NSAID use at baseline, NSAID use during the trial (incident NSAID use), and never users were described. The primary outcome was major bleeding. Secondary outcomes included clinically relevant nonmajor bleeding, gastrointestinal bleeding, heart failure hospitalization, stroke or systemic embolism, and all-cause mortality. NSAID use during the trial, and the interaction between randomized treatment, was analyzed using time-dependent Cox proportional hazards models. Results: Those with baseline NSAID use (n=832 [4.8%]), incident NSAID use (n=2185 [13.2%]), and never users were similar in median age (age [25th, 75th]; 70 [64, 77] versus 70 [63, 75] versus 70 [62, 76]). Those with NSAID use at baseline and incident NSAID use were more likely to have a history of bleeding than never users (24.5% versus 21.0% versus 15.6%, respectively). During a median follow-up (25th, 75th) of 1.8 (1.4, 2.3) years and when excluding those taking NSAID at baseline, we found that incident NSAID use was associated with an increased risk of major bleeding (hazard ratio [HR], 1.61 [95% CI, 1.11–2.33]) and clinically relevant nonmajor bleeding (HR, 1.70 [95% CI, 1.16–2.48]), but not gastrointestinal bleeding. No significant interaction was observed between NSAID use and randomized treatment for any outcome. Conclusions: A substantial number of patients in the ARISTOTLE trial took NSAIDs. Incident NSAID use was associated with major and clinically relevant nonmajor bleeding, but not with gastrointestinal bleeding. The safety and efficacy of apixaban versus warfarin appeared not significantly to be altered by NSAID use. This study warrants more investigation of the effect of NSAIDs on the outcomes of patients treated with apixaban. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00412984.
Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers
Shillington, Alicia C. , Macahilig, Cynthia, Diede, Scott J. , Dave, Vaidehi , Harshaw, Qing, Scherrer, Emilie , Liu, Frank Xiaoqing, Joseph, Richard W. , Lee, Todd A.

Mayo Clinic

Journal of Medical Economics | November 21, 2019 | Volume: 23 | Issue: 2 | Pages: 132-138

10.1080/13696998.2019.1696349 | PMID 31750751 Get It

Backstage Staff Communication: The Effects of Different Levels of Visual Exposure to Patients
Lim, Lisa , Kanfer, Ruth , Stroebel, Robert J. , Zimring, Craig , Lim, Lisa

Mayo Clinic

HERD: Health Environments Research & Design Journal | November 21, 2019 | Volume: 13 | Issue: 3 | Pages: 54-69

10.1177/1937586719888903 | PMID 31750738 Get It

Objective: This article examines how visual exposure to patients predicts patient-related communication among staff members. Background: Communication among healthcare professionals private from patients, or backstage communication, is critical for staff teamwork and patient care. While patients and visitors are a core group of users in healthcare settings, not much attention has been given to how patients’ presence impacts staff communication. Furthermore, many healthcare facilities provide team spaces for improved staff teamwork, but the privacy levels of team areas significantly vary. Method: This article presents an empirical study of four team-based primary care clinics where staff communication and teamwork are important. Visual exposure levels of the clinics were analyzed, and their relationships to staff members’ concerns for having backstage communication, including preferred and nonpreferred locations for backstage communication, were investigated. Results: Staff members in clinics with less visual exposure to patients reported lower concerns about having backstage communication. Staff members preferred talking in team areas that were visually less exposed to patients in the clinic, but, within team areas, the level of visual exposure did not matter. On the other hand, staff members did not prefer talking in visually exposed areas such as corridors in the clinic and visually exposed areas within team spaces. Conclusions: Staff members preferred talking in team areas, and they did not prefer talking in visually exposed areas. These findings identified visually exposed team areas as a potentially uncomfortable environment, with a lack of agreement between staff members’ preferences toward where they had patient-related communication.
Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics
Madamsetty, Vijay Sagar , Paul, Manash K. , Mukherjee, Anubhab , Mukherjee, Sudip , Madamsetty, Vijay S

Mayo Clinic

ACS Biomaterials Science & Engineering | November 21, 2019 | Volume: 6 | Issue: 1 | Pages: 167-181

10.1021/acsbiomaterials.9b01426 | PMID 33463233 Get It

Chinese physician perceptions regarding industry support of continuing medical education programs: a cross-sectional survey
Stephenson, Christopher R. , Qian, Qi , Mueller, Paul S. , Schleck, Cathy D. , Mandrekar, Jayawant N. , Beckman, Thomas J. , Wittich, Christopher M.

Mayo Clinic

Medical Education Online | November 21, 2019 | Volume: 25 | Issue: 1 | Pages: No page available

10.1080/10872981.2019.1694308 | PMID 31747854 Get It

Great Auricular Neuralgia: Case Series
Duvall, Jaclyn R., Garza, Ivan , Robertson, Carrie E. , Robertson, Carrie E , Kissoon, Narayan

Mayo Clinic

Headache: The Journal of Head and Face Pain | November 21, 2019 | Volume: 60 | Issue: 1 | Pages: 247-258

10.1111/head.13690 | PMID 31749202 Get It

Background/Objective The great auricular nerve (GAN) arises from C2‐C3 and provides innervation over the skin in the pre‐auricular region, jaw angle, posteroinferior pinna, and mastoid. Although damage to the GAN has been reported following trauma or procedures nearby this nerve course, neuralgia of this nerve is uncommon with knowledge based on a handful of case reports in literature. The objective of this study is to describe the presentation, treatment, and outcome of 13 cases of GAN neuralgia. Methods Case series . Retrospecive review of charts from 1994 to 2018 with diagnoses: “auricular neuralgia,” “auricular neuritis,” or “auricular neuropathy.” We included subjects with neuralgic pain within the distribution of the GAN, and excluded patients with atypical facial pain, GAN neuropathy, or unclear etiology. Results Of 79 charts, 13 patients met criteria (age at onset 11‐59; 11 women, 2 men). Pain was most often described as paroxysmal stabbing provoked by: turning the head (n = 7), touching the neck (n = 5), neck position during sleep (n = 2), jaw movement (n = 2), and other (n = 2). Seven patients received GAN blocks: all noted dramatic improvement in pain, including 3 who continued to receive serial blocks at our institution successfully for the next 2 to 5 years. Two patients successfully transitioned from GAN blocks to GAN stimulators. One patient with GAN lymphoma had resolution of pain following GAN resection. Conclusion GAN neuralgia should be considered in the differential for periauricular pain. GAN blocks or stimulators may be helpful for pain management.
Left atrial appendage isolation: The asymmetrically sharp double edge sword
Wen, Songnan , Barake, Walid , Asirvatham, Samuel J. , Barake, Walid M, Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | November 21, 2019 | Volume: 31 | Issue: 1 | Pages: 250-251

10.1111/jce.14287 | PMID 31749245 Get It

Natural history and clinical outcomes of inappropriate sinus tachycardia
Shabtaie, Samuel A. , Witt, Chance M. , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | November 21, 2019 | Volume: 31 | Issue: 1 | Pages: 137-143

10.1111/jce.14288 | PMID 31749258 Get It

AbstractBackgroundLimited data are available regarding the demographics, disease associations, and long‐term prognosis of patients with inappropriate sinus tachycardia (IST).ObjectiveTo establish epidemiologic data for patients with IST, including symptom onset, comorbid disease, and long‐term outcomes.MethodsWe retrospectively reviewed all patients with an IST diagnosis at the Mayo Clinic (Rochester, MN) during a 20‐year period (1998‐2018). We extracted demographic data and clinical outcomes compared to an age and gender‐matched control group with atrioventricular nodal reentry tachycardia (AVNRT).ResultsWithin the study period, a total of 305 patients with IST were identified (mean follow‐up 3.5 years) with 92.1% female and mean age 33.2 ± 11.2 years. The most frequently identified circumstances triggering the condition included pregnancy (7.9%) and infectious illness (5.9%) while the most common comorbid conditions were depression (25.6%) and anxiety (24.6%). At diagnosis, the mean left ventricular ejection fraction (LVEF) was 62.3 ± 6.2%, with 77 patients having follow‐up echocardiographic data. No significant difference in LVEF was seen after a mean 4.9 ± 4.3‐year follow‐up (baseline LVEF 59.8 ± 10.7% vs subsequent 61.4 ± 8.1%; P = .2971). Two deaths occurred within the study period, with one related to myocardial infarction and the other noncardiac; compared to an age and gender‐matched AVNRT control group there was no excess mortality during the follow‐up period.ConclusionsIn our study cohort, IST predominately affects young females with structurally normal hearts and modest coexistent psychiatric disease. In most cases of IST, a major event occurring just before or at the time of diagnosis could not be identified, although nearly 8% of patients first noted symptoms during or shortly after pregnancy. In our cohort, there was no evidence of cardiomyopathy or mortality related to IST.
Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
Grover, Michael , Grover, Lori L., Mookadam, Martina , Mi, Lanyu , Parish, James M., Grover, Michael L , Parish, James, Chang, Yu‐Hui

Mayo Clinic

Journal of Primary Care & Community Health | November 21, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2150132719886951 | PMID 31747842 Get It

Purpose: To test the association between participant King-Devick Test (KDT) times and obstructive sleep apnea (OSA) severity and evaluate for improvement after continuous positive airway pressure (CPAP) treatment. Methods: Study dates January 30 to July 31, 2018. Patients were referred for initial evaluation of sleep disordered breathing concerns. OSA severities were defined by Apnea Hypopnea Index (AHI) results, with ≥15 considered at least moderate OSA. The KDT is an objective physical measure of brain function. We estimated correlation between KDT time and AHI and compared mean KDT time between patients with and without moderate OSA. For the OSA subgroup, we evaluated for potential improvement in KDT after CPAP. Results: We enrolled 60 participants, of whom 35 (58.3%) had OSA with an AHI ≥15. Initial analyses noted no significant KDT time differences between patients based on OSA severity. However, after excluding 3 participants who had baseline neurologic illness, adjusted analyses demonstrated that mean KDT time was significantly prolonged for patients with moderate or greater OSA (AHI ≥15) as compared to those with mild or no sleep apnea (AHI <15); 63.4 seconds (95% CI 58.9-67.8) versus 55.7 seconds (95% CI 50.2-61.1), P = .03. CPAP-treated subjects demonstrated significantly improved KDT test times; 63.5 seconds mean pretreatment versus 55.6 posttreatment; −6.6 seconds mean difference, 95%CI (−12.0, −1.13), P = .02. Conclusion: Neurologic abnormalities in patients with OSA are potentially demonstrable utilizing this objective physical measure. Significant improvement is achieved in patients after CPAP treatment.